Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care, agreement signed between the two companies

Mr. Atul Vasani, Managing Director – Vaishali Pharma Ltd.

Ahmedabad (Gujarat) [India], April 20: Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma Ltd., a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

As per the agreement between the two companies, NSE-listed Vaishali Pharma Ltd. will take over the entire domestic and international marketing of Sankalp Life Care’s portfolio of nutraceutical products.

“This is a perfect partnership. Sankalp Life Care’s core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specializes in marketing. The partnership will allow us to leverage Vaishali Pharma’s marketing reach and focus on our expertise. It is a win-win for both companies, and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world,” said Dimple Goenka, Director, Sankalp Life Care.

Mrs. Dimple Goenka, Director – Sankalp Life Care

“This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian Pharma Industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care and make Sankalp Life Care’s 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial,” said Atul Vasani, Managing Director, Vaishali Pharma Ltd.

Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products, are made at the zero-discharge facility, which is fully operational now and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards, and the company has already made an application for USFDA approval for the facility.

Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.

Leave a Reply

Your email address will not be published.


Asian Granito India Ltd reports Consolidate Net Profit of Rs.91.8 crore, Cons. Net Sales of Rs.1563.8 crore in FY 22

Mr Kamlesh Patel, CMD and Mr Mukesh Patel, MD, Asian Granito India Ltd  Company recommends 7.00% dividend, Rs. 0.70 per share for FY 22; Led by volume growth and higher realization, company reported its highest ever Yearly Sales, EBITDA and Net Profit for the FY ended 31stMarch 2022  FY22 Results Highlights:– (Consolidated) ·         Net Profit […]

Read More

MSME Home Textile Sector Deeply Impacted With Spiralling Cotton Yarn Prices

Mumbai (Maharashtra) [India], May 26: Prospects for the Home Textile Sector to achieve the target set this year is extremely difficult despite the fact that the Industry had opened up entirely after the second wave of the Covid-19 Pandemic. The Home Textile Sector mainly comprises MSMEs. The Government of India has been highly Supportive. It […]

Read More

Empyrean Cashews betting big on growth

Mumbai, May 25: Empyrean Cashews Limited, a leading firm engaged in processing raw cashew nuts into finished cashew kernels with different grades and flavours aim to create a strong brand presence and hence is planning to set up 4 COCO outlets in Goa in Q2 FY23. In a bid to capture higher retail customers, the company is planning […]

Read More